Westpac Banking Corp Sells 3,647 Shares of HCA Healthcare, Inc. $HCA
by Jessica Moore · The Cerbat GemWestpac Banking Corp reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 30.6% during the third quarter, Holdings Channel reports. The firm owned 8,275 shares of the company’s stock after selling 3,647 shares during the period. Westpac Banking Corp’s holdings in HCA Healthcare were worth $3,531,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sunbelt Securities Inc. increased its holdings in shares of HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares in the last quarter. Sei Investments Co. boosted its stake in shares of HCA Healthcare by 27.5% during the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares in the last quarter. Darsana Capital Partners LP boosted its stake in shares of HCA Healthcare by 46.7% during the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock worth $428,879,000 after acquiring an additional 350,000 shares in the last quarter. Ulrich Consultants & Investment Group LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter worth $2,054,000. Finally, Fund 1 Investments LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth $975,000. 62.73% of the stock is owned by institutional investors and hedge funds.
HCA Healthcare Trading Down 3.3%
Shares of NYSE HCA opened at $460.55 on Friday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The firm has a market capitalization of $96.20 billion, a PE ratio of 15.89, a PEG ratio of 1.59 and a beta of 1.11. The business has a 50-day moving average price of $458.75 and a two-hundred day moving average price of $445.87.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share for the quarter, beating the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion for the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a negative return on equity of 198.52% and a net margin of 8.61%. The business’s revenue for the quarter was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.96 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 30.14 EPS for the current year.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is presently 10.34%.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, SVP Erica Rossitto sold 3,500 shares of the company’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $505.81, for a total value of $1,770,335.00. Following the transaction, the senior vice president owned 13,426 shares in the company, valued at approximately $6,791,005.06. This represents a 20.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael Schlosser sold 1,200 shares of the stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president owned 1,443 shares of the company’s stock, valued at approximately $713,779.95. The trade was a 45.40% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 36,413 shares of company stock worth $18,251,464. 1.50% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
Several brokerages have recently commented on HCA. Barclays upped their target price on HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a report on Thursday, October 29th. Truist Financial reissued a “buy” rating and issued a $510.00 target price (up from $495.00) on shares of HCA Healthcare in a research report on Tuesday, November 3rd. Bank of America upped their price target on shares of HCA Healthcare from $450.00 to $500.00 and gave the company a “neutral” rating in a research report on Wednesday, October 28th. TD Cowen lifted their price objective on shares of HCA Healthcare from $460.00 to $486.00 and gave the stock a “buy” rating in a research report on Wednesday, October 28th. Finally, Weiss Ratings raised shares of HCA Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a research note on Tuesday, November 10th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $482.30.
View Our Latest Stock Report on HCA Healthcare
HCA Healthcare Profile
HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).